Inguinal hernia
Conditions
Interventions
Experimental group: 38 patients received 900 mg of gabapentin capsuled one hour before undergoing inguinal hernioplasty surgery.
Control group: 37 patients received a placebo capsule one hour before u
Sponsors
santa casa de misericordia
santa casa de misericordia
Eligibility
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Both genders; age between 18 and 60 years; Maximum BMI of 30; scheduled for inguinal hernioplasty at Hospital São José do Avaí.
Exclusion criteria
Exclusion criteria: Patients with chronic opioid use; patients with chronic pain; history of chemical dependency; or those allergic to any of the medications used in the study; cardiac respiratory renal or hepatic pathology; BMI above 30 kg /m2; relapsed hernias and inguino-scrotal hernias.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected outcome #1: Reduction of post-operative pain, assessed by visual analog scale. Data was collected from 4 hours after surgery to a period of 30 days.;Outcome found #1: Patients who received gabapentin had lower levels of postoperative pain compared to patients who received placebo | — |
Secondary
| Measure | Time frame |
|---|---|
| Expected outcome #2: Reduction in postoperative morphine consumption. Data were collected up to 24 hours and on the thirtieth day after inguinal hernioplasty surgery.;Outcome found #2: Patients who received gabapentin perioperatively consumed less morphine compared to the group who received placebo. Results were seen at 4 hours and 24 hours after inguinal hernioplasty surgery. | — |
Countries
Brazil
Contacts
Public ContactGlaucio Costa
Outcome results
None listed